Epilepsy is a chronic neurological disorder that affects people of all ages. Around 50 million people worldwide have epilepsy. Notwithstanding limitations with the existing antiepileptic drugs, new drug therapies with efficacy against drug-resistant seizures, favourable adverse events profiles, especially in regard to neurological and psychiatric effects, and, if possible, low costs to patients and high worldwide availability are clearly needed. Herbal therapy is one of the potential options for treating seizure disorder mentioned in ancient texts of Ayurveda, Unani system of medicine. This thesis aimed to verify and evaluate reported beneficiary effect & clinical ethnopractice of herbal resourced thymoquinone (from Nigella sativa) and safranal (Crocus sativus) in epilepsy treatment followed by reengineering of their traditional way of clinical use by applying nanotechnology (nanometric formulation) for preparing nanosized novel formulation for administering through nasal route to get superior delivery system for seizure control with low and defined dose in animal models of epilepsy.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Dr. Shadab Ahmad Pathan did Ph.D. from Hamdard University, New Delhi under the supervision of Prof. Roop Krishen Khar. He did his M.Pharm. from BITS, Pilani. He has worked with Wockhardt Research Centre as a Formulation Scientist. At present he is working with Glaxosmithkline Ltd
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Epilepsy is a chronic neurological disorder that affects people of all ages. Around 50 million people worldwide have epilepsy. Notwithstanding limitations with the existing antiepileptic drugs, new drug therapies with efficacy against drug-resistant seizures, favourable adverse events profiles, especially in regard to neurological and psychiatric effects, and, if possible, low costs to patients and high worldwide availability are clearly needed. Herbal therapy is one of the potential options for treating seizure disorder mentioned in ancient texts of Ayurveda, Unani system of medicine. This thesis aimed to verify and evaluate reported beneficiary effect & clinical ethnopractice of herbal resourced thymoquinone (from Nigella sativa) and safranal (Crocus sativus) in epilepsy treatment followed by reengineering of their traditional way of clinical use by applying nanotechnology (nanometric formulation) for preparing nanosized novel formulation for administering through nasal route to get superior delivery system for seizure control with low and defined dose in animal models of epilepsy. 460 pp. Englisch. N° de réf. du vendeur 9783659225536
Quantité disponible : 2 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Epilepsy is a chronic neurological disorder that affects people of all ages. Around 50 million people worldwide have epilepsy. Notwithstanding limitations with the existing antiepileptic drugs, new drug therapies with efficacy against drug-resistant seizures, favourable adverse events profiles, especially in regard to neurological and psychiatric effects, and, if possible, low costs to patients and high worldwide availability are clearly needed. Herbal therapy is one of the potential options for treating seizure disorder mentioned in ancient texts of Ayurveda, Unani system of medicine. This thesis aimed to verify and evaluate reported beneficiary effect & clinical ethnopractice of herbal resourced thymoquinone (from Nigella sativa) and safranal (Crocus sativus) in epilepsy treatment followed by reengineering of their traditional way of clinical use by applying nanotechnology (nanometric formulation) for preparing nanosized novel formulation for administering through nasal route to get superior delivery system for seizure control with low and defined dose in animal models of epilepsy. N° de réf. du vendeur 9783659225536
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Ahmad Pathan ShadabDr. Shadab Ahmad Pathan did Ph.D. from Hamdard University, New Delhi under the supervision of Prof. Roop Krishen Khar. He did his M.Pharm. from BITS, Pilani. He has worked with Wockhardt Research Centre as a Formul. N° de réf. du vendeur 5141152
Quantité disponible : Plus de 20 disponibles
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Epilepsy is a chronic neurological disorder that affects people of all ages. Around 50 million people worldwide have epilepsy. Notwithstanding limitations with the existing antiepileptic drugs, new drug therapies with efficacy against drug-resistant seizures, favourable adverse events profiles, especially in regard to neurological and psychiatric effects, and, if possible, low costs to patients and high worldwide availability are clearly needed. Herbal therapy is one of the potential options for treating seizure disorder mentioned in ancient texts of Ayurveda, Unani system of medicine. This thesis aimed to verify and evaluate reported beneficiary effect & clinical ethnopractice of herbal resourced thymoquinone (from Nigella sativa) and safranal (Crocus sativus) in epilepsy treatment followed by reengineering of their traditional way of clinical use by applying nanotechnology (nanometric formulation) for preparing nanosized novel formulation for administering through nasal route to get superior delivery system for seizure control with low and defined dose in animal models of epilepsy.OmniScriptum SRL, Str. Armeneasca 28/1, office 1, 2012 Chisinau 460 pp. Englisch. N° de réf. du vendeur 9783659225536
Quantité disponible : 1 disponible(s)